-
Whole Exome Sequencing Analysis of Carfilzomib-Related Cardiotoxicity in Multiple Myeloma Patients
Study
phs003308
-
Germline Genome Sequencing from Patients with Early-Onset Merkel Cell Carcinoma
Study
phs003485
-
PD-1 Instructs a Tumor Suppressive Metabolic Program to Restrain AP-1 Activity in T Cell Lymphoma
Study
phs003312
-
Resistance Development in Basal Cell Nevus Syndrome through the Basal to Squamous Transition
Study
phs003415
-
Pathogenesis and Immunity in Endemic Burkitt Lymphoma
Study
phs001282
-
HTAN MCL Pre-Cancer Atlas Pilot Project - Targeted Sequencing Development Study
Study
phs002225
-
NIDCD Otitis Media Genetic Susceptibility and Middle Ear Microbial Shifts
Study
phs001941
-
A Phase I Study with a Personalized Neoantigen Cancer Vaccine in Melanoma
Study
phs001451
-
A Phase I Study With a Personalized Neoantigen Cancer Vaccine in Glioblastoma Multiforme
Study
phs001519
-
Sequencing Lymphoma
Study
phs001229
-
National Cancer Institute (NCI) TARGET: Therapeutically Applicable Research to Generate Effective Treatments
Study
phs000218
-
University of Michigan Clinical Sequencing Exploratory Research (CSER)
Study
phs000673
-
CPTAC Proteogenomic Study
Study
phs001287
-
Gabriella Miller Kids First (GMKF) Pediatric Research Program in Susceptibility to Ewing Sarcoma Based on Germline Risk and Familial History of Cancer
Study
phs001228
-
National Cancer Institute Cancer Genome Characterization Initiative (CGCI)
Study
phs000235
-
Single-cell multi-omic profiling of glioblastoma-associated myeloid cells
Study
EGAS00001004871
-
WES of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007301
-
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM
Study
EGAS00001007286
-
ENCORAFENIB COMBINED WITH BINIMETINIB FOR BRAFV600E-MUTATED RELAPSED/REFRACTORY MULTIPLE MYELOMA: THE PHASE II GMMG-BIRMA TRIAL (Hipo_K08K)
Study
EGAS00001005973
-
Single cell and plasma RNA sequencing
Study
EGAS00001005194
-
Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial
Study
EGAS00001007421
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Integrative Profiling of T790M Negative EGFR Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Study
EGAS00001005389
-
Epithelioid haemangioendothelioma (EHE) case series from the Stafford Fox Rare Cancer Program
Study
EGAS00001007474
-
Clear cell sarcoma sequencing data
Study
EGAS00001006072
-
Study of the microenvironment of angioimmunoblastic T-cell lymphoma
Study
EGAS00001006401
-
Single-cell profiling of co-cultures of GSCCs and macrophages
Study
EGAS00001007482
-
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
Study
EGAS00001007486
-
Comparison of EGF and PDGF driven glioblastomas.
Study
EGAS00001001900
-
Oncoprint GSCCs
Study
EGAS00001007481
-
Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients
Study
EGAS00001005580
-
Whole genome sequencing of tumour and normal paired samples of diffuse intrinsic pontine gliomas
Study
EGAS00001000572
-
Unraveling the genetics of transformed splenic marginal zone lymphoma
Study
EGAS00001006389
-
Spatial and temporal genomic evolution in glioblastoma
Study
EGAS00001001033
-
Characterizing the tumor immune microenvironment of ependymomas using targeted gene expression profiles and RNA-sequencing the pros and cons
Study
EGAS00001006535
-
DNA methylation and somatic mutations converge on cell cycle and define similar evolutionary histories in brain tumors
Study
EGAS00001001255
-
Single cell RNA sequencing of bone marrow mononuclear cells
Study
EGAS00001006836
-
3D-GSC_expression_profiles
Study
EGAS00001007182
-
Integrated genomic characterization of IDH1 mutant Glioma malignant progression
Study
EGAS00001001588
-
Molecular evolution of classic Hodgkin lymphoma revealed through whole genome sequencing of Hodgkin and Reed Sternberg cells
Study
EGAS00001006884
-
Genomic profiling of localized (lFL) and systemic follicular lymphoma (sFL) reveals novel insights into FL pathogenesis
Study
EGAS00001006927
-
VRK3 depletion in Pontine Diffuse Midline Glioma (DMG)-K27 altered cells
Study
EGAS00001007047
-
MutWP1__CRUK_Grand_Challenge_Mutographs_of_Cancer__Oesophageal_squamous_cell_carcinoma
Study
EGAS00001002725
-
Study of complex rearrangements and mutational signatures in neuroblastoma heterogeneous risk groups.
Study
EGAS00001006983
-
Neuroblastoma heterogeneity
Study
EGAS00001007016
-
Linked-read based analysis of Medulloblastomas
Study
EGAS00001007064
-
Establishment and characterization of an Epstein-Barr virus-positive cell line from a non-keratinizing differentiated primary nasopharyngeal carcinoma
Study
EGAS00001007172
-
Single-cell RNA-seq data of the tumor microenvironment of lymphocyte-rich Hodgkin lymphoma and other Hodgkin lymphoma subtypes
Study
EGAS00001005541
-
an integrated molecular study of clear cell renal cell carcinoma (ccRCC) including whole-genome/exome and RNA sequencing as well as array-based gene expression/copy-number/methylation analyses
Study
EGAS00001000509
-
RNAseq_of_healthy_mesothelial_cells_and_primary_mesothelioma_cell_lines
Study
EGAS00001005728
-
Single cell multi-omic data of glioblastoma evolution under therapy
Study
EGAS00001004909
-
The Spatial Heterogeneity in Multiple Myeloma - from the Subclonal Architecture to the Immune Microenvironment (partly hipo_K08K)
Study
EGAS00001006090
-
Y90 radioembolization followed by intravenous Nivolumab for advanced hepatocellular carcinoma
Study
EGAS00001006834
-
Spatial genomic heterogeneity in multiple myeloma revealed by multi- region sequencing
Study
EGAS00001002111
-
Single-cell profiling maps the spectrum of crosstalk between glioma cells and tumor associated macrophages
Study
EGAS00001002185
-
TRACERx Renal 100
Study
EGAS00001002793
-
Enhanced detection of circulating tumor DNA by fragment size analysis
Study
EGAS00001003258
-
Single-cell RNA sequencing on single CD45+ immune cells isolated from peripheral blood, lymphnode, ascites, tumour and adjacent normal tissues from six hepatocellular carcinoma patients.
Study
EGAS00001003449
-
Combined gene expression and digital pathology identifies molecular mediators of T cell exclusion and immune suppression in ovarian cancer
Study
EGAS00001003487
-
The 3D evolution of glioma cell populations
Study
EGAS00001003710
-
Sporadic and endemic Burkitt lymphoma have frequent FOXO1 mutations but distinct hotspots in the AKT recognition motif
Study
EGAS00001003719
-
A single-cell atlas of human glioma
Study
EGAS00001003845
-
Roma Sequencing Study
Study
EGAS00001004287
-
Whole-exome sequencing of hepatocellular carcinoma biopsies (proteogenomic study)
Study
EGAS00001005073
-
Multimodal single-cell and bulk glioma analyses
Study
EGAS00001005300
-
Sequential single-cell transcriptional and protein marker profiling reveals TIGIT as a marker of CD19 CAR-T cell dysfunction in patients with non-Hodgkin’s lymphoma
Study
EGAS00001005356
-
Mutational landscape of high-grade B-cell lymphoma with MYC-, BCL2 and/or BCL6 rearrangements characterized by whole-exome sequencing
Study
EGAS00001005420
-
Spatial concordance of DNA methylation classification in diffuse glioma
Study
EGAS00001005434
-
Targeted sequencing of diffuse large B-cell lymphoma tumour samples from the UK's Haematological Malignancy Research Network
Study
EGAS00001005953
-
Molecular programs of melanoma brain metastases (MBM)
Study
EGAS00001005976
-
Microenvironment subtypes and association with tumor cell mutations and antigen expression in follicular lymphoma
Study
EGAS00001006052
-
Whole-Transcriptomic Profiling of Sorted Human Renal Cell Carcinoma Immune Populations
Study
EGAS00001006593
-
NIBIT-M4 Clinical Trial samples
Study
EGAS00001006736
-
Diet driven microbial ecology underpins associations between cancer immunotherapy outcomes and the gut microbiome
Study
EGAS00001006982
-
Molecular features of adenomas predicting metachronous colorectal cancer: a nested-case control study
Study
EGAS00001007039
-
The genomic landscape of recurrent ovarian high grade serous carcinoma: the BriTROC-1 study
Study
EGAS00001007292
-
Whole-genome sequencing analysis of low-grade astrocytomas within the ICGC PedBrain Tumor Project
Study
EGAS00001000381
-
Genetic landscape of pediatric Rhabdomyosarcoma
Study
EGAS00001000256
-
Study of non-clear cell renal cell carcinoma
Study
EGAS00001000926
-
Spatio-temporal evolution of the primary glioblastoma genome
Study
EGAS00001001041
-
Immune trajectory of response and adverse effect in immunotherapy-treated hepatocellular carcinoma
Study
EGAS00001004843
-
Identification of gene mutations and fusion genes in patients with Sézary Syndrome
Study
EGAS00001001706
-
Gene expression profiling of nasopharyngeal carcinoma
Study
EGAS00001004542
-
Conserved interferon-gamma signaling and decreased immune exclusion programs in responses to immune checkpoint blockade therapy
Study
EGAS00001004545
-
Genomic analysis of patient-derived xenograft models reveals intratumor-heterogeneity in endometrial cancer and can predict tumor growth inhibition with talazoparib
Study
EGAS00001004666
-
Genetic landscape of pediatric Osteosarcoma
Study
EGAS00001000263
-
Pre-neoplastic liver colonization by 11p15.5 altered mosaic cells in young children with hepatoblastoma
Study
EGAS00001006692
-
The whole genome landscape of Burkitt lymphoma subtypes
Study
EGAS00001003778
-
Genetic Landscape of Esophageal Squamous Cell Carcinoma Defined by Exome Sequencing on Chinese Patient Cohort and Cell Lines
Study
EGAS00001000932
-
Single-cell RNA sequencing of 22 Hodgkin lymphoma tumors and 5 reactive lymph nodes
Study
EGAS00001004085
-
Whole genome and RNA sequencing of paediatric glioblastoma in the ICGC PedBrain project
Study
EGAS00001001139
-
Mutations in the SIX1/2 pathway and the DROSHA/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors
Study
EGAS00001000906
-
Integrated genetic analysis of primary CNS lymphoma
Study
EGAS00001007222
-
A clinically applicable connectivity signature for glioblastoma includes the tumor network driver CHI3L1
Study
EGAS00001007611
-
in silico drug target prediction for melanoma
Study
EGAS00001006463
-
shallow WGS and deep targeted panel on ctDNA in rhabdomyosarcomas
Study
EGAS00001007399
-
Single cell RNA sequencing of normal endometrial derived organoids uncovers novel cell type markers for prognostication
Study
EGAS00001004466
-
Single cell RNA sequencing of relapsed/refractory multiple myeloma
Study
EGAS00001004805
-
RNA-seq of Liver Cancer
Study
EGAS00001002879
-
The impact of mutational clonality in predicting the response to anti-PD-L1/PD-L1 in advanced urothelial cancer
Study
EGAS00001007086